Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Generex reports preliminary results from two trials of its mealtime insulin Generex Oral-lyn

July 11, 2011

Amsterdam Molecular Therapeutics requests reexamination of MAA for gene therapy Glybera

July 8, 2011

Amylin Pharmaceuticals, Lilly and Alkermes report on tQT study of Bydureon

July 8, 2011

Zafgen secures financing for phase II trial in obesity

July 8, 2011

Roche discloses new glycogen synthase activators

July 8, 2011

Novartis claims new acetyl-CoA carboxylase 2 inhibitors

July 7, 2011

Relin and MingSight join to develop MS-553 for diabetes-related eye disease

July 7, 2011

Once-monthly minodronic acid formulation approved in Japan

July 6, 2011

Preclinical and clinical phase I and II data reported on antidiabetes agent MK-0893

July 6, 2011

Preclinical and phase I data show LY-2409021 lowers glucose

July 6, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...